AbbVievsMettler-Toledo International

ABBV and MTD stock compared: price, dividend, valuation and results, from SEC filings.

MTD

Mettler-Toledo International, Inc.

$1,738.91

Value $35.3B

+0.46%
MTD's page

AbbVie (ABBV) has a market value of $522B and Mettler-Toledo International (MTD) $35.3B. Over the last year, with dividends, ABBV moved +30.3% and MTD +20.1%. The P/E is 50.7 for ABBV and 37.8 for MTD. Dividend yield: ABBV 2.35%, MTD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    MTD$35.3B

    ABBV is 15 times MTD

  • Revenue, 12 months

    ABBV$66.0B

    MTD$4.2B

    ABBV is 16 times MTD

  • Net income, 12 months

    ABBV$10.3B

    MTD$934M

    ABBV is 11 times MTD

  • Operating margin

    ABBV32.2%

    MTD–

  • ROIC

    ABBV25.7%

    MTD44.5%

    18.8 points apart

  • P/E

    ABBV50.7

    MTD37.8

    ABBV is 1.3 times MTD

  • Dividend yield

    ABBV2.4%

    MTD0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    MTD+13.4%

    188.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

MTD+13.4%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsMTDWith dividends
1 year since November 12, 2025+30.3%Price +26.5%+20.1%Price +20.1%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%+70.6%+19.5% a yearPrice +70.6%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%+13.4%+2.5% a yearPrice +13.4%
10 years since November 15, 2016+605.5%+21.6% a yearPrice +369.3%+307.6%+15.1% a yearPrice +307.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieMTDMettler-Toledo International

Valuation

ABBVMTD
Valuation
Price$295.03$1,738.91
Market value$522B$35.3B
Enterprise value (EV)$592B$37.3B
P/E50.737.8
P/E, 5-year median57.033.8
P/B––
EV/EBIT27.933.1
Free cash flow yield3.6%2.5%

Results and growth

ABBVMTD
Results and growth
Revenue, 12 months$66.0B$4.2B
Net income, 12 months$10.3B$934M
Free cash flow, 12 months$18.9B$871M
Earnings per share, 12 months$5.81$46.10
Revenue growth, year on year8.6%4.0%
Revenue growth a year, past+5.9%over 5 years+5.5%over 5 years
EPS growth a year, past-2.8%over 5 years+11.0%over 5 years

Margins and returns on capital

ABBVMTD
Margins and returns on capital
Gross margin73.7%60.4%
Operating margin32.2%–
Net margin15.7%22.3%
ROIC25.7%44.5%
ROE––

Balance sheet

ABBVMTD
Balance sheet
Cash$10.8B$52M
Total debt$80.9B$2.0B
Net debt / EBITDA3.21.7
Interest cover7.1×16.8×

Dividends and buybacks

ABBVMTD
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%2.3%
Shareholder yield2.5%2.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or MTD

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Mettler-Toledo International?

By market value, AbbVie ($522B) is about 14.8 times Mettler-Toledo International ($35.3B), at today's prices.

How did ABBV and MTD stock do over the last 10 years?

Since November 15, 2016, ABBV's price moved +369.3% and MTD's +307.6%. With dividends: ABBV +605.5% (+21.6% a year), MTD +307.6% (+15.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or MTD?

The dividend yield at today's price is 2.35% for AbbVie and none for Mettler-Toledo International. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and MTD?

At today's price, the P/E is 50.7 for ABBV and 37.8 for MTD. The median of the last five years was 57.0 and 33.8, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Mettler-Toledo International?

Over the last twelve months, the net margin was 15.7% for AbbVie and 22.3% for Mettler-Toledo International, and the operating margin 32.2% and –. Revenue was $66.0B and $4.2B.

Which is the better investment, AbbVie or Mettler-Toledo International?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.